5) Components of the trafficking regulatory subnetwork are highly expressed in HER2+ breast cancers expressing high levels of αVβ6 and affect patient survival and αVβ6 expression predicts relapse following trastuzumab treatment. The gene discussed is ERBB2; the disease is breast carcinoma.